MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
10.75
-0.54 (-4.78%)
At close: Jun 27, 2025, 4:00 PM
10.76
+0.01 (0.09%)
After-hours: Jun 27, 2025, 7:38 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $359.31 million as of June 27, 2025.
Market Cap
359.31M
Enterprise Value
118.66M
1-Year Change
n/a
Ranking
Category
Stock Price
10.75
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $359.31M, a decrease of -29.50%. That is a compound annual growth rate of -35.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 377.36M | -38.73% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |